HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,650,000
- Total 13F shares
- 123,583,310
- Share change
- -918,262
- Total reported value
- $5,026,636,534
- Put/Call ratio
- 65%
- Price per share
- $40.68
- Number of holders
- 409
- Value change
- -$29,500,183
- Number of buys
- 209
- Number of sells
- 192
Quarterly Holders Quick Answers
What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 40637H109:
Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
15%
|
18,630,963
|
$688,600,393 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
13,259,514
|
$490,071,638 | — | 31 Dec 2023 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
5.4%
|
6,689,058
|
$247,227,584 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
5.2%
|
6,475,549
|
$239,336,291 | — | 31 Dec 2023 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
3%
|
3,709,599
|
$142,948,381 | — | 31 Dec 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.8%
|
3,463,694
|
$128,018,130 | — | 31 Dec 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.7%
|
3,282,640
|
$121,326,000 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.5%
|
3,093,932
|
$114,351,719 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,919,763
|
$107,926,610 | — | 31 Dec 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.8%
|
2,226,538
|
$82,293,000 | — | 31 Dec 2023 | |
| Invesco Ltd. |
13F
|
Company |
1.6%
|
2,030,634
|
$75,052,232 | — | 31 Dec 2023 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
1.6%
|
1,983,916
|
$73,325,535 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.6%
|
1,973,744
|
$72,949,578 | — | 31 Dec 2023 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
1.6%
|
1,921,659
|
$71,025,000 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.4%
|
1,736,122
|
$64,167,069 | — | 31 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
1,613,113
|
$59,621,956 | — | 31 Dec 2023 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.3%
|
1,576,083
|
$58,252,028 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
1,541,610
|
$56,977,906 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.2%
|
1,525,202
|
$56,371,465 | — | 31 Dec 2023 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
1.2%
|
1,518,455
|
$56,122,097 | — | 31 Dec 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
1,389,837
|
$51,369,000 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
1,293,476
|
$47,806,873 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
1,281,117
|
$47,350,126 | — | 31 Dec 2023 | |
| NORGES BANK |
13F
|
Company |
0.98%
|
1,215,769
|
$44,934,822 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.96%
|
1,187,659
|
$43,895,878 | — | 31 Dec 2023 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.94%
|
1,163,033
|
$42,985,700 | — | 31 Dec 2023 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.77%
|
949,324
|
$35,087,015 | — | 31 Dec 2023 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.73%
|
897,347
|
$33,165,000 | — | 31 Dec 2023 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.67%
|
832,422
|
$30,766,317 | — | 31 Dec 2023 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.59%
|
727,998
|
$26,906,801 | — | 31 Dec 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.58%
|
711,235
|
$26,287,256 | — | 31 Dec 2023 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.54%
|
662,816
|
$24,497,679 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.53%
|
656,684
|
$24,271,055 | — | 31 Dec 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.52%
|
646,168
|
$23,882,370 | — | 31 Dec 2023 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.48%
|
591,332
|
$21,855,631 | — | 31 Dec 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.45%
|
560,808
|
$20,727,463 | — | 31 Dec 2023 | |
| Boston Partners |
13F
|
Company |
0.45%
|
552,392
|
$20,217,591 | — | 31 Dec 2023 | |
| 2Xideas AG |
13F
|
Company |
0.44%
|
544,166
|
$20,112,375 | — | 31 Dec 2023 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.41%
|
504,542
|
$19,788,137 | — | 31 Dec 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.4%
|
499,701
|
$18,468,000 | — | 31 Dec 2023 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.39%
|
480,796
|
$17,770,180 | — | 31 Dec 2023 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.38%
|
474,734
|
$17,546,169 | — | 31 Dec 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.38%
|
464,907
|
$17,182,957 | — | 31 Dec 2023 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.37%
|
462,400
|
$17,090,000 | — | 31 Dec 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.37%
|
459,369
|
$16,978,277 | — | 31 Dec 2023 | |
| Mesirow Institutional Investment Management, Inc. |
13F
|
Company |
0.37%
|
453,827
|
$16,773,446 | — | 31 Dec 2023 | |
| MIZUHO MARKETS AMERICAS LLC |
13F
|
Company |
0.36%
|
446,661
|
$16,508,591 | — | 31 Dec 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.35%
|
429,164
|
$15,861,871 | — | 31 Dec 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.35%
|
428,214
|
$15,826,790 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.34%
|
415,406
|
$15,353,406 | — | 31 Dec 2023 |
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q1 2024
As of 31 Mar 2024,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
409 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
123,583,310 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, SNYDER CAPITAL MANAGEMENT L P, Artisan Partners Limited Partnership, ALLIANCEBERNSTEIN L.P., JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, MACQUARIE GROUP LTD, and TD Asset Management Inc.
This page lists
411
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
409
Q1 2024 holders
409
Holder diff
0
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.